JPRN-jRCT1080222497未知4 期
Clinical Pharmaclogical study of TS-071 in Patient With Type 2 Diabetetes Mellitus(Evaluation of glycemic variability using continuous glucose monitoring)
Taisho Pharmaceutical co., LTD0 个研究点目标入组 40 人开始时间: 2014年5月27日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Type 2 diabetes mellitus
排除标准
- •- Having non-type 2 diabetes mellitus.
- •- Having critical Heart Disease, other ciruculatory disease, cerebrovascular disorder, pancreatic disease and hematologic disease.
研究者
相似试验
未知
1 期
Phase 1 Clinical Study of TS-071 in Healthy Adult Male Subjects (Single-Dose Administration)Healthy Japanese male subjectsJPRN-jRCT2080222304Taisho Pharmaceutical co., LTD57
未知
2 期
Double-blind, Phase2 Study of TS-071 in Patients With Type 2 Diabetes Mellitus (Confirmatory Study of Dose-Response)Type 2 Diabetes MellitusJPRN-jRCT2080221156Taisho Pharmaceutical co., LTD275
未知
1 期
Phase 1 Clinical Study of TS-071 in Healthy Male Adults (Repeated Administration)Healthy Japanese male subjectsJPRN-jRCT2080222305Taisho Pharmaceutical co., LTD24
未知
4 期
A Long-Term Clinical Study of TS-071 as Combination Therapy in Patients With Type 2 Diabetes on insulin therapyType 2 Diabetes MellitusJPRN-jRCT1080222531Taisho Pharmaceutical co., LTD225
未知
4 期
A Long-Term Clinical Study of TS-071 as Combination Therapy With GLP-1 Receptor Agonist in Patients With Type 2 Diabetes MellitusType 2 Diabetes MellitusJPRN-jRCT1080222532Taisho Pharmaceutical co., LTD70